Suppression of SMAD3 activity was shown to depress fibrosis, apoptosis, and inflammation in mouse kidneys with unilateral ureteral obstruction and inhibited the development of diabetic nephropathy in a mouse model of type 1 diabetes (58, 59). This evidence concerns the gene SMAD3 and diabetic kidney disease.